What we do

Product Development

Currently, the Tecnimede Group has a portfolio of more than 130 products that have been developed in-house and manages more than 4,300 marketing authorisations worldwide. Our medications are marketed directly or through partnerships in almost all countries of the European Union and in several countries in North Africa, Asia, the Middle East, and the Americas.

Developing new molecules

We research and develop new chemical entities to identify new and improved solutions to meet the needs of the population.

Finished Product

We have the capacity to develop a wide variety of pharmaceutical forms such as oral solids, oral liquids, semi-solids, and injectables.

Pipeline

The Tecnimede Group has more than 80 research projects in progress.

Opportunities

At the Tecnimede Group, we are constantly looking for new value propositions in the most diverse areas, such as licensing, co-promotion, co-marketing, distribution, and co-development. If you would like to collaborate with the Tecnimede Group, please contact us by e-mail: gtm@tecnimede.pt

Opportunities

In-licensing 

This is one of our main areas of interest, with a view to enhancing the portfolio of all subsidiaries and business areas.

 

Out-licensing

We offer a wide range of products for licensing in various therapeutic areas in Portugal and worldwide. Have a look at our portfolio here.

 

Release of products for the European area

We have a certified laboratory with extensive experience in releasing batches for the European area.

Production

The Tecnimede Group supports its production activities across two production units of excellence, focused on innovation and quality. These facilities comply with the strict certification criteria of various state entities worldwide. The two production units, which supplement each other, allow us to offer products using more than 170 active ingredients in various pharmaceutical forms.

Production Capacity

Atlantic Pharma has a production capacity of 30 million packs and Atlas Pharm 3 million packs, which together amounts to a production capacity of 33 million packs per year.

Contracting Services for Manufacturing

Our production units also work together with partners looking to outsource the production of products in various pharmaceutical forms in order to gain competitive advantages for their supply chain.

Commercial Collaborations

We are continuously exploring new strategic partnerships for our commercial areas.

Generic Medication

Through Tecnigen, we aim to meet all the needs of the outpatient and hospital sector.

Branding and Innovation

Differentiation through innovation is the key factor behind Tecnimede's dynamic approach and recognition.

Consumer Healthcare

We strive to make consumers aware of their active participation in the management of their health and well-being.

Partnerships

The presence of the Tecnimede Group both locally and worldwide has grown exponentially in recent years. This is due to recognition of the quality of our products and services and the resulting success of the partnerships established. Thus the Tecnimede Group's vast network of partners, with whom we collaborate on a wide array of projects, is a vital part of this process.